20 20 Biolabs Inc stock is traded at $0.1571, with a volume of 301,482. It is down -13.01% in the last 24 hours and down -40.72% over the past month. 20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
Previous Close:
$0.1806
Open:
$0.1802
24h Volume:
301,482
Relative Volume:
1.49
Market Cap:
$2.20M
Revenue:
$1.85M
Net Income/Loss:
-$5.56M
P/E Ratio:
-
EPS:
-$0.7583
Net Cash Flow:
-
1W Performance:
-23.10%
1M Performance:
-40.72%
6M Performance:
-87.82%
1Y Performance:
0.00%
1-Day Range:
$0.1556$0.1803
1-Week Range:
$0.1556$0.2058
52-Week Range:
$0.1556$50.00
20 20 Biolabs Inc Stock (AIDX) Company Profile
Name
20 20 Biolabs IncSector
HealthcareIndustry
Medical DevicesPhone
(240) 453-6339Address
9430 KEY WEST AVENUE, ROCKVILLE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS